Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05534932 · ClinicalTrials.gov registry record · NA
Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women
A NA study of Preeclampsia Postpartum, sponsored by University of Chicago.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05534932 is a NA study of Preeclampsia Postpartum that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 20 participants, below the 72-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05534932, a NA study of Preeclampsia Postpartum, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global Longitudinal Strain (GLS).
Conditions Studied
Interventions
- DEVICE Remote Patient Monitoring
Study Locations (1)
Illinois
- University of Chicago Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-10-27 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05534932
The ClinicalTrials.gov registry entry for NCT05534932 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 72-participant average among 8 other Preeclampsia Postpartum trials with a reported enrollment target (72% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preeclampsia Postpartum appearing as the primary indexed condition, and to 1 intervention - of which Remote Patient Monitoring is the first listed.
NCT05534932 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05534932 about?
NCT05534932 is a clinical study titled "Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women". This is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global Longitudinal Strain (GLS).
What is the current status of trial NCT05534932?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-10-27. Estimated completion is 2026-11-01.
What conditions does trial NCT05534932 study?
This clinical trial studies the following conditions: Preeclampsia Postpartum.
What interventions are being tested in trial NCT05534932?
The interventions under investigation include: Remote Patient Monitoring (DEVICE).
Who is sponsoring clinical trial NCT05534932?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05534932 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia Postpartum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preeclampsia Educational Program Study (PrEPS)
ACTIVE NOT RECRUITING · NA
-
A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes
COMPLETED · NA
-
Aspirin for Postpartum Patients With Preeclampsia
RECRUITING · Phase 2
-
Postpartum Low-Dose Aspirin and Preeclampsia
RECRUITING · Phase 2
-
Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
RECRUITING · Early Phase 1
-
Aspirin and Preeclampsia
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.